ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0611

Proteomics Reveals Dysregulated Molecular Mechanisms of Cell Death in Neutrophils in Rheumatoid Arthritis

Jennifer Amsler1, Constance Beaudouin2, Morgane LeGall3, Géraldine Falgarone4, François Rannou5, Léa Tourneur3 and Véronique Witko-Sarsat3, 1Institute Cochin, Schoenenwerd, Switzerland, 2Hôpital Privé de Provence, Aix-en-Provence, France, 3Institute Cochin, Paris, France, 4Hôpital Avicenne, Paris, France, 5Hôpital Cochin, Paris, France

Meeting: ACR Convergence 2022

Keywords: Apoptosis, Cell Death, neutrophils, proteomics, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Favoring apoptosis of neutrophils infiltrating the joints of patients suffering from rheumatoid arthritis (RA) and perpetuating inflammation has recently been discussed as an alternative therapeutic strategy. We therefore wanted to identify the dysregulated molecular pathways of cell death in neutrophils of patients with RA.

Methods: We performed a proteomic analysis of the cytosolic proteins of neutrophils isolated from the blood of 3 healthy donors, 3 RA patients in remission and from the synovial fluid of 4 RA patients with a disease flare. Functional analysis was generated through the use of the software Ingenuity Pathway Analysis (IPA). Results were then confirmed by western blot analysis.

Results: Our proteomic analysis identified 2232 quantified proteins overall, out of which 64 were differentially expressed between RA blood and joint neutrophils. 43 were differentially expressed between RA blood and control blood and 83 were differentially expressed between RA joint and control blood neutrophils. Based on the differentially expressed proteins, IPA suggested a dysregulation of the death pathways in neutrophils isolated from blood and joint of RA patients. Most importantly, ferroptosis was one of the main signaling pathways modified in joint neutrophils of RA patients compared to blood neutrophils of healthy controls. Further, the pathway of pyroptosis was suggested to be disturbed in joint neutrophils compared to both blood neutrophils of RA patients as well as healthy controls. We identified seven proteins involved in ferroptosis that were differentially expressed between the three groups: arachidonate 15-lipoxygenase (ALOX15), ferritin heavy chain (FTH1), ADP-ribosylation factor 1, 4, 5 (ARF1, ARF4, ARF5), histone macro-H2A (MACROH2A1), cysteine-tRNA ligase (CARS1). Preliminary results of our western blot analysis confirmed the different expression of two proteins involved in ferroptosis (FTH1 and ALOX15).

Conclusion: We herein uncover that ferroptosis-associated proteins are dysregulated in neutrophils from patients with RA. Our results suggest that this pathway could be a future track of research for novel treatment strategy to achieve a short-term remission substituting corticosteroids, thus reducing their side effects.

Supporting image 1

Principal component analysis performed on logged LFQ (label free quantification) values of differentially expressed proteins segregates cytosol of blood neutrophils of healthy controls (grey), blood neutrophils of RA patients (green) and joint neutrophils of RA patients (blue).

Supporting image 2

Hierarchical clustering of differentially expressed proteins (rows) and samples (columns) based on their distance using Pearson correlation.
C = blood neutrophils of healthy controls – A = blood neutrophils of RA patients – J = joint neutrophils of RA patients.
Color intensity indicates expression levels. The heatmap is coded red for increasing and green for decreasing. The colored bar on the bottom indicates how the heat map colors are related to the standard score (z-score).


Disclosures: J. Amsler, None; C. Beaudouin, None; M. LeGall, Chugaï-Roche; G. Falgarone, None; F. Rannou, None; L. Tourneur, None; V. Witko-Sarsat, None.

To cite this abstract in AMA style:

Amsler J, Beaudouin C, LeGall M, Falgarone G, Rannou F, Tourneur L, Witko-Sarsat V. Proteomics Reveals Dysregulated Molecular Mechanisms of Cell Death in Neutrophils in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/proteomics-reveals-dysregulated-molecular-mechanisms-of-cell-death-in-neutrophils-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proteomics-reveals-dysregulated-molecular-mechanisms-of-cell-death-in-neutrophils-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology